Literature DB >> 19147397

Odontogenic tumors: a study of 1309 cases in a Chinese population.

Hai-Yan Luo1, Tie-Jun Li.   

Abstract

To determine the relative frequency of odontogenic tumors (OTs) in a Chinese population, files from the department of oral pathology, Peking University School and Hospital of Stomatology, were systematically reviewed for all OTs during the period 1985-2006. Diagnosis of each case was confirmed according to the WHO histological classification for OTs published in 2005. The relevant clinicopathological data of these OTs were analyzed and compared with those of previous series. The present series represents approximately 3.92% of all pathologic specimens accessioned in our department over the same period of time. Of the 1309 OTs, 94.04% were benign and 5.06% were malignant. The most frequent benign tumor was keratocystic odontogenic tumor (38.73%), followed by ameloblastoma (36.52%) and odontomas (6.11%). The prevalence of the remaining tumors appears to be rare. In conclusion, odontogenic tumors are in general uncommon lesions in this Chinese population. The present study identifies some similarities between our data and the previous studies from Africa and Asia and some differences in comparison to the reports from American and European countries.

Entities:  

Mesh:

Year:  2009        PMID: 19147397     DOI: 10.1016/j.oraloncology.2008.11.001

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  53 in total

1.  Odontogenic tumours: a 25-year epidemiological study in the Marche region of Italy.

Authors:  Marco Mascitti; Lucrezia Togni; Giuseppe Troiano; Vito Carlo Alberto Caponio; Antonio Sabatucci; Andrea Balercia; Corrado Rubini; Lorenzo Lo Muzio; Andrea Santarelli
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-14       Impact factor: 2.503

2.  Odontogenic tumours: A review of 266 cases.

Authors:  Ahmed O Lawal; Akinyele O Adisa; Adeola A Olusanya
Journal:  J Clin Exp Dent       Date:  2013-02-01

3.  Expression of phosphorylated mTOR and its regulatory protein is related to biological behaviors of ameloblastoma.

Authors:  Ning Li; Ming Zhong; Ming Song
Journal:  Int J Clin Exp Pathol       Date:  2012-09-05

4.  An unusual odontogenic myxoma in mandible and submandibular region: a rare case report.

Authors:  Y-J Guo; G Li; Y Gao; X-C Ma
Journal:  Dentomaxillofac Radiol       Date:  2014-10-01       Impact factor: 2.419

5.  Clinicopathological and cell proliferation evaluation of ameloblastomas and keratocystic odontogenic tumors: a 10 year retrospective study.

Authors:  Leorik Pereira da Silva; Marianna Sampaio Serpa; Thalita Santana; George João Ferreira do Nascimento; Emanuel Sávio de Souza Andrade; Ana Paula Veras Sobral
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-17       Impact factor: 2.503

6.  Distribution of mast cells in benign odontogenic tumors.

Authors:  Francisco de Assis Caldas Pereira; Clarissa Araújo Silva Gurgel; Eduardo Antônio Gonçalves Ramos; Manuela Torres Andion Vidal; Antônio Luiz Barbosa Pinheiro; Vladimir Jurisic; Caroline Brandi Schlaepfer Sales; Patrícia Ramos Cury; Jean Nunes dos Santos
Journal:  Tumour Biol       Date:  2011-11-30

7.  A review of 156 odontogenic tumours in Calabar, Nigeria.

Authors:  C E Anyanechi; B D Saheeb
Journal:  Ghana Med J       Date:  2014-09

Review 8.  Keratocystic odontogenic tumour: systematic review.

Authors:  D S MacDonald-Jankowski
Journal:  Dentomaxillofac Radiol       Date:  2011-01       Impact factor: 2.419

Review 9.  Clinical parameter of odontoma with special emphasis on treatment of impacted teeth-a retrospective multicentre study and literature review.

Authors:  Peer W Kämmerer; Daniel Schneider; Eik Schiegnitz; Sarah Schneider; Christian Walter; Bernhard Frerich; Martin Kunkel
Journal:  Clin Oral Investig       Date:  2015-11-27       Impact factor: 3.573

10.  Expression of RECK and matrix metalloproteinase-2 in ameloblastoma.

Authors:  Bin Zhang; Jin Zhang; Zhi-Ying Xu; Hong-Liang Xie
Journal:  BMC Cancer       Date:  2009-12-08       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.